Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 1, 2013, Pages 75-81

  Erickson, Kevin F ^a,b   Lea, Janice ^c   McClellan, William M ^c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OUTCOME VARIABLE; PREDICTOR VARIABLE; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR;

ADULT; AFRICAN AMERICANS; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UNITED STATES;

EID: 84872183855     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03340412     Document Type: Article

References (25)

1. National Kidney Foundation;: K/DOQI clinical practice guide-lines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[2 Suppl 1]: S1-S266, 2002
2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
3. US Renal Data System;: USRDS 2009 annual data report: Atlas of end-stage renal disease in the United States. In: National Institutes of Health, Bethesda, MD, US Renal Data System, 2009
4. Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT Jr; AASK Study Group;: A comparison of iothalamate-GFR and serum creatinine-based outcomes: Acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 15: 3175-3183, 2004
5. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
7. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J: End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 277: 1293-1298, 1997
8. Norris KC, Greene T, Kopple J, Lea J, Lewis J, Lipkowitz M, Miller P, Richardson A, Rostand S, Wang X, Appel LJ: Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol 17: 2928-2936, 2006
9. Lea J, Cheek D, Thornley-Brown D, Appel L, Agodoa L, Contreras G, Gassman J, Lash J, Miller ER 3rd, Randall O, Wang X, McClellan W; AASK Study Investigators;: Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J Kidney Dis 51: 732-740, 2008
10. Collett D: Modeling Survival Data in Medical Research, 2nd Ed., Boca Raton, FL, Chapman & Hall/CRC, 2003
11. Rubin D: Multiple Imputation for Nonresponse in Surveys, New York, John Willey & Sons, 1987
12. Allison PD: Missing Data, Thousand Oaks, CA, Sage Publications, Inc., 2001
13. McClellan WM, Warnock DG, Judd S, Muntner P, Kewalramani R, Cushman M, McClure LA, Newsome BB, Howard G: Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol 22: 1721-1728, 2011
14. Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD: Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol 17: 1444-1452, 2006
15. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M; Alberta Kidney Disease Network;: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303: 423-429, 2010
16. Largo R, Gómez-Garre D, Soto K, Marrón B, Blanco J, Gazapo RM, Plaza JJ, Egido J: Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 33: 732-739, 1999
17. Wang SN, LaPage J, Hirschberg R: Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int 57: 1002-1014, 2000
18. Yu HT: Progression of chronic renal failure. Arch Intern Med 163: 1417-1429, 2003
19. Hayslett JP: Functional adaptation to reduction in renal mass. Physiol Rev 59: 137-164, 1979
20. Johnson HA, Vera Roman JM: Compensatory renal enlargement. Hypertrophy versus hyperplasia. Am J Pathol 49: 1-13, 1966
21. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
22. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL: The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: Results of the African American study of kidney disease and hypertension. Arch Intern Med 165: 947-953, 2005
23. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837-1847, 1998
24. Taal MW, Brenner BM: Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int 70: 1694-1705, 2006
25. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for GFR and Risk Factors for Clinical Outcomes, Erickson et al. 81 progression of chronic kidney disease to kidney failure. JAMA 305: 1553-1559, 2011